1. Home
  2. GLMD vs JCSE Comparison

GLMD vs JCSE Comparison

Compare GLMD & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • JCSE
  • Stock Information
  • Founded
  • GLMD 2000
  • JCSE 1999
  • Country
  • GLMD Israel
  • JCSE Singapore
  • Employees
  • GLMD N/A
  • JCSE N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • GLMD Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • GLMD Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • GLMD 5.9M
  • JCSE 5.4M
  • IPO Year
  • GLMD 2014
  • JCSE 2022
  • Fundamental
  • Price
  • GLMD $2.80
  • JCSE $1.13
  • Analyst Decision
  • GLMD
  • JCSE
  • Analyst Count
  • GLMD 0
  • JCSE 0
  • Target Price
  • GLMD N/A
  • JCSE N/A
  • AVG Volume (30 Days)
  • GLMD 66.9K
  • JCSE 43.2K
  • Earning Date
  • GLMD 11-29-2024
  • JCSE 10-30-2024
  • Dividend Yield
  • GLMD N/A
  • JCSE N/A
  • EPS Growth
  • GLMD N/A
  • JCSE N/A
  • EPS
  • GLMD N/A
  • JCSE 0.12
  • Revenue
  • GLMD N/A
  • JCSE $14,723,999.00
  • Revenue This Year
  • GLMD N/A
  • JCSE N/A
  • Revenue Next Year
  • GLMD N/A
  • JCSE N/A
  • P/E Ratio
  • GLMD N/A
  • JCSE $9.44
  • Revenue Growth
  • GLMD N/A
  • JCSE N/A
  • 52 Week Low
  • GLMD $2.73
  • JCSE $0.60
  • 52 Week High
  • GLMD $23.80
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 37.59
  • JCSE 44.40
  • Support Level
  • GLMD $2.84
  • JCSE $1.06
  • Resistance Level
  • GLMD $3.05
  • JCSE $1.25
  • Average True Range (ATR)
  • GLMD 0.24
  • JCSE 0.14
  • MACD
  • GLMD 0.04
  • JCSE -0.01
  • Stochastic Oscillator
  • GLMD 8.33
  • JCSE 14.00

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.

Share on Social Networks: